These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16283486)

  • 1. A PSP94-derived peptide PCK3145 inhibits MMP-9 secretion and triggers CD44 cell surface shedding: implication in tumor metastasis.
    Annabi B; Bouzeghrane M; Currie JC; Hawkins R; Dulude H; Daigneault L; Ruiz M; Wisniewski J; Garde S; Rabbani SA; Panchal C; Wu JJ; Béliveau R
    Clin Exp Metastasis; 2005; 22(5):429-39. PubMed ID: 16283486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of MMP-9 secretion by the anti-metastatic PSP94-derived peptide PCK3145 requires cell surface laminin receptor signaling.
    Annabi B; Bouzeghrane M; Currie JC; Dulude H; Daigneault L; Garde S; Rabbani SA; Panchal C; Wu JJ; Béliveau R
    Anticancer Drugs; 2006 Apr; 17(4):429-38. PubMed ID: 16550001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prostate secretory protein94-derived synthetic peptide PCK3145 inhibits VEGF signalling in endothelial cells: implication in tumor angiogenesis.
    Lamy S; Ruiz MT; Wisniewski J; Garde S; Rabbani SA; Panchal C; Wu JJ; Annabi B
    Int J Cancer; 2006 May; 118(9):2350-8. PubMed ID: 16331603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the infiltrating character of brain tumors: inhibition of RhoA/ROK-mediated CD44 cell surface shedding from glioma cells by the green tea catechin EGCg.
    Annabi B; Bouzeghrane M; Moumdjian R; Moghrabi A; Béliveau R
    J Neurochem; 2005 Aug; 94(4):906-16. PubMed ID: 15992376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of the 37-kDa laminin receptor precursor in the anti-metastatic PSP94-derived peptide PCK3145 cell surface binding.
    Annabi B; Currie JC; Bouzeghrane M; Dulude H; Daigneault L; Garde S; Rabbani SA; Panchal C; Wu JJ; Béliveau R
    Biochem Biophys Res Commun; 2006 Jul; 346(1):358-66. PubMed ID: 16759641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration.
    Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS
    Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A synthetic 15-mer peptide (PCK3145) derived from prostate secretory protein can reduce tumor growth, experimental skeletal metastases, and malignancy-associated hypercalcemia.
    Shukeir N; Arakelian A; Chen G; Garde S; Ruiz M; Panchal C; Rabbani SA
    Cancer Res; 2004 Aug; 64(15):5370-7. PubMed ID: 15289344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability of PCK3145, a synthetic peptide derived from prostate secretory protein 94 (PSP94) in metastatic hormone-refractory prostate cancer.
    Hawkins RE; Daigneault L; Cowan R; Griffiths R; Panchal C; Armstrong A; Fenemore J; Irvine A; Sereda K; Dulude H
    Clin Prostate Cancer; 2005 Sep; 4(2):91-9. PubMed ID: 16197609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta induces CD44 cleavage that promotes migration of MDA-MB-435s cells through the up-regulation of membrane type 1-matrix metalloproteinase.
    Kuo YC; Su CH; Liu CY; Chen TH; Chen CP; Wang HS
    Int J Cancer; 2009 Jun; 124(11):2568-76. PubMed ID: 19243022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
    Hwang HJ; Park HJ; Chung HJ; Min HY; Park EJ; Hong JY; Lee SK
    J Nutr Biochem; 2006 May; 17(5):356-62. PubMed ID: 16214327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.
    Desai B; Rogers MJ; Chellaiah MA
    Mol Cancer; 2007 Mar; 6():18. PubMed ID: 17343740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells.
    Bourguignon LY; Gunja-Smith Z; Iida N; Zhu HB; Young LJ; Muller WJ; Cardiff RD
    J Cell Physiol; 1998 Jul; 176(1):206-15. PubMed ID: 9618160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polarized MT1-MMP-CD44 interaction and CD44 cleavage during cell retraction reveal an essential role for MT1-MMP in CD44-mediated invasion.
    Marrero-Diaz R; Bravo-Cordero JJ; Megías D; García MA; Bartolomé RA; Teixido J; Montoya MC
    Cell Motil Cytoskeleton; 2009 Jan; 66(1):48-61. PubMed ID: 19023892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MT1-MMP recognition by ERM proteins and its implication in CD44 shedding.
    Terawaki S; Kitano K; Aoyama M; Mori T; Hakoshima T
    Genes Cells; 2015 Oct; 20(10):847-59. PubMed ID: 26289026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronan cell surface binding is induced by type I collagen and regulated by caveolae in glioma cells.
    Annabi B; Thibeault S; Moumdjian R; Béliveau R
    J Biol Chem; 2004 May; 279(21):21888-96. PubMed ID: 15016831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate secretory protein of 94 amino acids (PSP-94) and its peptide (PCK3145) as potential therapeutic modalities for prostate cancer.
    Shukeir N; Garde S; Wu JJ; Panchal C; Rabbani SA
    Anticancer Drugs; 2005 Nov; 16(10):1045-51. PubMed ID: 16222145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PSP94 contributes to chemoresistance and its peptide derivative PCK3145 represses tumor growth in ovarian cancer.
    Yan BX; Ma JX; Zhang J; Guo Y; Riedel H; Mueller MD; Remick SC; Yu JJ
    Oncogene; 2014 Nov; 33(45):5288-94. PubMed ID: 24186202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCK3145 inhibits proliferation and induces apoptosis in breast and colon cancer cells.
    Kostopoulos A; Papageorgiou E; Koutsilieris M; Sivolapenko G
    Anticancer Res; 2015 Mar; 35(3):1377-84. PubMed ID: 25750288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase.
    Suenaga N; Mori H; Itoh Y; Seiki M
    Oncogene; 2005 Jan; 24(5):859-68. PubMed ID: 15558018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased invasion and expression of MMP-9 in human colorectal cell lines by a CD44-dependent mechanism.
    Murray D; Morrin M; McDonnell S
    Anticancer Res; 2004; 24(2A):489-94. PubMed ID: 15152948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.